Drug-Associated Pemphigus Reported by Physicians: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

Abstract

Get full access to this article

View all access options for this article.

References

Schmidt

Kasperkiewicz

Joly

. Pemphigus. Lancet. 2019;394(10201):882-894. doi:10.1016/S0140-6736(19)31778-7

Kaplan

Potter

Fox

. Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol. 1992;26(2 Pt 2):364-366. doi:10.1016/0190-9622(92)70057-m

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB